S, B., A, L., M, M., W, R., P, M., T, D., . . . S, S. (2025). Translational investigations in the HN1901 phase II window-of-opportunity study investigating the biological activity of an IDO1 (IO102) and PD-L1 (IO103) immune-modulatory peptide cancer vaccines in squamous cell carcinoma of the head and neck. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 282(11), 5841. https://doi.org/10.1007/s00405-025-09655-8
Chicago Style (17th ed.) CitationS, Beyaert, et al. "Translational Investigations in the HN1901 Phase II Window-of-opportunity Study Investigating the Biological Activity of an IDO1 (IO102) and PD-L1 (IO103) Immune-modulatory Peptide Cancer Vaccines in Squamous Cell Carcinoma of the Head and Neck." European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 282, no. 11 (2025): 5841. https://doi.org/10.1007/s00405-025-09655-8.
MLA (9th ed.) CitationS, Beyaert, et al. "Translational Investigations in the HN1901 Phase II Window-of-opportunity Study Investigating the Biological Activity of an IDO1 (IO102) and PD-L1 (IO103) Immune-modulatory Peptide Cancer Vaccines in Squamous Cell Carcinoma of the Head and Neck." European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, vol. 282, no. 11, 2025, p. 5841, https://doi.org/10.1007/s00405-025-09655-8.